![Marcel Walser, Director Lead Generation of Swiss biotechnology company Molecular Partners works in a laboratory at the company's headquarters in Schlieren, Switzerland August 11, 2020. REUTERS/Arnd Wiegmann Stock Photo - Alamy Marcel Walser, Director Lead Generation of Swiss biotechnology company Molecular Partners works in a laboratory at the company's headquarters in Schlieren, Switzerland August 11, 2020. REUTERS/Arnd Wiegmann Stock Photo - Alamy](https://c8.alamy.com/comp/2CB7RJ8/marcel-walser-director-lead-generation-of-swiss-biotechnology-company-molecular-partners-works-in-a-laboratory-at-the-companys-headquarters-in-schlieren-switzerland-august-11-2020-reutersarnd-wiegmann-2CB7RJ8.jpg)
Marcel Walser, Director Lead Generation of Swiss biotechnology company Molecular Partners works in a laboratory at the company's headquarters in Schlieren, Switzerland August 11, 2020. REUTERS/Arnd Wiegmann Stock Photo - Alamy
![Leadhunter kg | Akademie Telemarketing Lead Generation Vertrieb, Telesales, Aqua, Call-Center, Datenbank png | PNGWing Leadhunter kg | Akademie Telemarketing Lead Generation Vertrieb, Telesales, Aqua, Call-Center, Datenbank png | PNGWing](https://w7.pngwing.com/pngs/899/201/png-transparent-leadhunter-kg-academy-telemarketing-lead-generation-sales-telesales-heart-teal-germany.png)
Leadhunter kg | Akademie Telemarketing Lead Generation Vertrieb, Telesales, Aqua, Call-Center, Datenbank png | PNGWing
![PDF) Lead generation--enhancing the success of drug discovery by investing in the hit to lead process PDF) Lead generation--enhancing the success of drug discovery by investing in the hit to lead process](https://i1.rgstatic.net/publication/279877344_Lead_generation--enhancing_the_success_of_drug_discovery_by_investing_in_the_hit_to_lead_process/links/559d04a508aeafbd3f2733b7/largepreview.png)
PDF) Lead generation--enhancing the success of drug discovery by investing in the hit to lead process
![Marcel Walser, Director Lead Generation of Swiss biotechnology company Molecular Partners displays a petri dish containing bacterial colonies in a laboratory at the company's headquarters in Schlieren, Switzerland August 11, 2020. REUTERS/Arnd Marcel Walser, Director Lead Generation of Swiss biotechnology company Molecular Partners displays a petri dish containing bacterial colonies in a laboratory at the company's headquarters in Schlieren, Switzerland August 11, 2020. REUTERS/Arnd](https://c8.alamy.com/comp/2CB7RT3/marcel-walser-director-lead-generation-of-swiss-biotechnology-company-molecular-partners-displays-a-petri-dish-containing-bacterial-colonies-in-a-laboratory-at-the-companys-headquarters-in-schlieren-switzerland-august-11-2020-reutersarnd-wiegmann-2CB7RT3.jpg)